Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Defining the ionic mechanisms of optogenetic control of vascular tone by channelrhodopsin-2.

Rorsman NJG, Ta CM, Garnett H, Swietach P, Tammaro P.

Br J Pharmacol. 2018 Jun;175(11):2028-2045. doi: 10.1111/bph.14183. Epub 2018 Apr 17.

2.

Contrasting effects of phosphatidylinositol 4,5-bisphosphate on cloned TMEM16A and TMEM16B channels.

Ta CM, Acheson KE, Rorsman NJG, Jongkind RC, Tammaro P.

Br J Pharmacol. 2017 Sep;174(18):2984-2999. doi: 10.1111/bph.13913. Epub 2017 Aug 10.

3.

Mechanism of allosteric activation of TMEM16A/ANO1 channels by a commonly used chloride channel blocker.

Ta CM, Adomaviciene A, Rorsman NJ, Garnett H, Tammaro P.

Br J Pharmacol. 2016 Feb;173(3):511-28. doi: 10.1111/bph.13381. Epub 2016 Jan 18.

4.

A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus.

Frodermann V, Chau TA, Sayedyahossein S, Toth JM, Heinrichs DE, Madrenas J.

J Infect Dis. 2011 Jul 15;204(2):253-62. doi: 10.1093/infdis/jir276.

PMID:
21673036
5.

Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.

Chau TA, McCully ML, Brintnell W, An G, Kasper KJ, Vinés ED, Kubes P, Haeryfar SM, McCormick JK, Cairns E, Heinrichs DE, Madrenas J.

Nat Med. 2009 Jun;15(6):641-8. doi: 10.1038/nm.1965.

PMID:
19465927
6.

Structure-Function analysis of the CTLA-4 interaction with PP2A.

Teft WA, Chau TA, Madrenas J.

BMC Immunol. 2009 Apr 30;10:23. doi: 10.1186/1471-2172-10-23.

7.

Dendritic cell differentiation induced by a self-peptide derived from apolipoprotein E.

Stephens TA, Nikoopour E, Rider BJ, Leon-Ponte M, Chau TA, Mikolajczak S, Chaturvedi P, Lee-Chan E, Flavell RA, Haeryfar SM, Madrenas J, Singh B.

J Immunol. 2008 Nov 15;181(10):6859-71.

8.

Receptor-interacting protein 2 is a marker for resolution of peritoneal dialysis-associated peritonitis.

McCully ML, Baroja ML, Chau TA, Jain AK, Barra L, Salgado A, Blake PG, Madrenas J.

Kidney Int. 2007 Nov;72(10):1273-81. Epub 2007 Sep 12.

9.

Characterization of human peritoneal dendritic cell precursors and their involvement in peritonitis.

McCully ML, Chau TA, Luke P, Blake PG, Madrenas J.

Clin Exp Immunol. 2005 Mar;139(3):513-25.

10.

Regulation of T-cell activation by phosphodiesterase 4B2 requires its dynamic redistribution during immunological synapse formation.

Arp J, Kirchhof MG, Baroja ML, Nazarian SH, Chau TA, Strathdee CA, Ball EH, Madrenas J.

Mol Cell Biol. 2003 Nov;23(22):8042-57.

11.
12.
13.

Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A.

Baroja ML, Vijayakrishnan L, Bettelli E, Darlington PJ, Chau TA, Ling V, Collins M, Carreno BM, Madrenas J, Kuchroo VK.

J Immunol. 2002 May 15;168(10):5070-8.

14.

CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.

Carreno BM, Bennett F, Chau TA, Ling V, Luxenberg D, Jussif J, Baroja ML, Madrenas J.

J Immunol. 2000 Aug 1;165(3):1352-6.

Supplemental Content

Loading ...
Support Center